MediPharm Labs Corp logo

MediPharm Labs Corp

TSX:LABS (Canada)  
C$ 0.07 (+8.33%) Dec 24
At Loss
P/B:
0.55
Market Cap:
C$ 24.67M ($ 18.61M)
Enterprise V:
C$ 12.23M ($ 8.52M)
Volume:
93.39K
Avg Vol (2M):
235.50K
Trade In:
Volume:
93.39K
At Loss
Avg Vol (2M):
235.50K

Business Description

Description
MediPharm Labs Corp is a pharmaceutical company specializing in precision-based cannabinoids. The Company operates in one reportable segment, the production and sales of cannabis flower, extracts, and derivative products. Through its wholesale and white-label platforms, MediPharm Labs formulates, develops, processes, packages, and distributes cannabis extracts and cannabinoid-based products to domestic and international markets. Geographically the company has a presence in Canada, Australia, Germany, and other countries and the majority of revenue derives from Canada.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 20.02
Equity-to-Asset 0.81
Debt-to-Equity 0.02
Debt-to-EBITDA -0.08
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -2.75
Distress
Grey
Safe
Beneish M-Score -3.46
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 53.67
9-Day RSI 50.26
14-Day RSI 48.99
6-1 Month Momentum % -13.33
12-1 Month Momentum % 8.33

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.21
Quick Ratio 2.36
Cash Ratio 1.22
Days Inventory 129.08
Days Sales Outstanding 59.59
Days Payable 37.81

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -37.2
Shareholder Yield % -1.41

Financials

TSX:LABS's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

MediPharm Labs Corp Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil C$) 39.05
EPS (TTM) (C$) -0.04
Beta 1.09
Volatility % 37.36
14-Day RSI 48.99
14-Day ATR (C$) 0.005451
20-Day SMA (C$) 0.06525
12-1 Month Momentum % 8.33
52-Week Range (C$) 0.06 - 0.1
Shares Outstanding (Mil) 411.12

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

MediPharm Labs Corp Filings

Filing Date Document Date Form
No Filing Data

MediPharm Labs Corp Stock Events

Financials Calendars
Event Date Price(C$)
No Event Data

MediPharm Labs Corp Frequently Asked Questions

What is MediPharm Labs Corp(TSX:LABS)'s stock price today?
The current price of TSX:LABS is C$0.07. The 52 week high of TSX:LABS is C$0.10 and 52 week low is C$0.06.
When is next earnings date of MediPharm Labs Corp(TSX:LABS)?
The next earnings date of MediPharm Labs Corp(TSX:LABS) is .
Does MediPharm Labs Corp(TSX:LABS) pay dividends? If so, how much?
MediPharm Labs Corp(TSX:LABS) does not pay dividend.

Press Release

Subject Date
No Press Release